FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, particularly to pharmaceutical industry, and describes a tabletted oral dosage form containing desloratadine in an amount of 3 to 15%, processing additives and a pharmaceutically acceptable excipient. The processing additives consist of sodium croscarmellose, magnesium stearate and povidone. The excipient represents a mixture of lactose disaccharide and microcrystalline cellulose polysaccharide in ratio from 2:1 to 8:1. Lactose and microcrystalline cellulose have an average particle size from 30 to 200 mcm. Producing the table involves granulating desloratadine, lactose and microcrystalline cellulose.
EFFECT: invention provides reducing granulate compression force, increasing process capability and maintaining the high quality of the tablets.
9 cl, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| WATER-DISPERSIBLE DESLORATADINE PILL AND METHOD FOR ITS MANUFACTURE | 2015 |
|
RU2631619C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING DESLORATADINE (VERSIONS) | 2013 |
|
RU2537169C1 |
| CHEMICALLY STABLE AND THERMOSTABLE READY FORMS OF NORASTEMIZOL | 1998 |
|
RU2214245C2 |
| TABLET PREPARING BY DIRECT PRESSING AND COMPRISING 4-AMINO-1-HYDROXYBUTYLIDENE-1,1-BISPHOSPHONIC ACID AS ACTIVE COMPONENT | 2001 |
|
RU2279273C2 |
| DESMOPRESSIN-CONTAINING SOLID PHARMACEUTICAL FORMULATION | 2004 |
|
RU2290945C2 |
| SODIUM IBUPROFEN TABLETS AND METHODS FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING SODIUM IBUPROFEN | 2010 |
|
RU2715680C2 |
| DESMOPRESSIN PHARMACEUTICAL COMPOSITION AS SOLID DOSED MEDICINAL FORMULATION AND METHOD FOR ITS PREPARING | 2004 |
|
RU2303439C2 |
| COMPOSITION AND METHOD OF DIRECT COMPRESSING | 2005 |
|
RU2391097C2 |
| LACTOSE-FREE, NONHYGROSCOPIC AND ANHYDROUS PHARMACEUTICAL PREPARATIONS OF DESCARBOETHOXYLORATADINE | 1998 |
|
RU2209627C2 |
| COMPOSITION AND METHOD FOR DIRECT PRESSING | 2005 |
|
RU2766487C2 |
